Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2

PLoS Pathog. 2020 May 21;16(5):e1008556. doi: 10.1371/journal.ppat.1008556. eCollection 2020 May.
No abstract available

MeSH terms

  • ABO Blood-Group System*
  • Angiotensin-Converting Enzyme 2
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / immunology*
  • Coronavirus Infections / transmission
  • Glycosylation
  • Humans
  • Immunity, Innate*
  • Pandemics
  • Peptidyl-Dipeptidase A
  • Pneumonia, Viral / immunology*
  • Pneumonia, Viral / transmission
  • Polysaccharides / immunology*
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus / immunology

Substances

  • ABO Blood-Group System
  • Polysaccharides
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2

Grants and funding

No specific funding sources besides the authors' institutional support.